Literature DB >> 3081574

Calcium dependency and free calcium concentrations during insulin secretion in a hamster beta cell line.

A E Boyd, R S Hill, J M Oberwetter, M Berg.   

Abstract

Using a glucose-responsive beta cell line, we tested the hypothesis that the free cytosolic Ca2+ concentration ([Ca2+]i) is the primary signal that couples a stimulus to insulin secretion, and examined the involvement of the extracellular Ca2+ pool in this process. Glucose or depolarization of the beta cell with 40 mM K+ stimulated a monophasic release of insulin directly proportional to the extracellular Ca2+ concentration. 40 mM K+ increased 45Ca2+ uptake and increased [Ca2+]i, which was measured with quin 2, 4.7-fold, from 56 +/- 3 to 238 +/- 17 nM. With high glucose, 45Ca2+ uptake did not increase, and [Ca2+]i was unchanged or fell slightly. There was a striking correlation between inhibitory effects of verapamil, the Ca2+ channel blocker, on insulin secretion and the rise in [Ca2+]i evoked by K+. Higher concentrations of verapamil were required to inhibit glucose- than K+-stimulated insulin secretion (dose giving half-maximal effect of 1.4 X 10(-4) M vs. 6.0 X 10(-7) M). Incubation in Ca2+-free, 1 mM EGTA buffer for 30 min lowered [Ca2+]i to 14 +/- 2 nM, and inhibited acute insulin release to both secretagogues. If high glucose was present in the Ca2+-free period, reintroduction of 2.5 mM Ca2+ in high glucose restored insulin secretion only to the basal rate. However, if low glucose was present during the Ca2+-free period, high glucose and 2.5 mM Ca2+ triggered a full first-phase insulin response. These data suggest that high glucose generates a non-Ca2+ signal that turns over rapidly and provide direct evidence that K+ triggers insulin release by drawing extracellular Ca2+ into the beta cell through verapamil-sensitive Ca2+ channels. However, an increase [Ca2+]i is not the primary signal that evokes glucose-stimulated insulin release in this beta cell line.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3081574      PMCID: PMC423463          DOI: 10.1172/JCI112374

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  Biphasic insulin release in rat islets of Langerhans and the role of Intracellular Ca++ stores.

Authors:  M Kikuchi; C B Wollheim; E G Siegel; A E Renold; G W Sharp
Journal:  Endocrinology       Date:  1979-10       Impact factor: 4.736

2.  Studies on the dual effects of glucose on 45Ca++ efflux from isolated rat islets.

Authors:  M Kikuchi; C B Wollheim; G S Cuendet; A E Renold; G W Sharp
Journal:  Endocrinology       Date:  1978-05       Impact factor: 4.736

3.  The roles of intracellular and extracellular Ca++ in glucose-stimulated biphasic insulin release by rat islets.

Authors:  C B Wollheim; M Kikuchi; A E Renold; G W Sharp
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

4.  Effect of verapamil on contractility, oxygen utilization, and calcium exchangeability in mammalian heart muscle.

Authors:  W G Nayler; J Szeto
Journal:  Cardiovasc Res       Date:  1972-03       Impact factor: 10.787

5.  The stimulus-secretion coupling of glucose-induced insulin release. 3. Uptake of 45 calcium by isolated islets of Langerhans.

Authors:  F Malaisse-Lagae; W J Malaisse
Journal:  Endocrinology       Date:  1971-01       Impact factor: 4.736

6.  Electrical activity in pancreatic islet cells.

Authors:  P M Dean; E K Matthews
Journal:  Nature       Date:  1968-07-27       Impact factor: 49.962

Review 7.  Turnover of inositol phospholipids and signal transduction.

Authors:  Y Nishizuka
Journal:  Science       Date:  1984-09-21       Impact factor: 47.728

8.  Electrical characteristics of pancreatic islet cells.

Authors:  E K Matthews; Y Sakamoto
Journal:  J Physiol       Date:  1975-03       Impact factor: 5.182

9.  Cation requirements for insulin secretion in the isolated perfused pancreas.

Authors:  G M Grodsky; L L Bennett
Journal:  Diabetes       Date:  1966-12       Impact factor: 9.461

10.  Calcium antagonists and islet function: VII. Effect of calcium deprivation.

Authors:  W J Malaisse; J C Hutton; A Sener; J Levy; A Herchuelz; G Devis; G Somers
Journal:  J Membr Biol       Date:  1978-01-18       Impact factor: 1.843

View more
  8 in total

Review 1.  Localized calcium influx in pancreatic beta-cells: its significance for Ca2+-dependent insulin secretion from the islets of Langerhans.

Authors:  L S Satin
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

2.  Comparative study of K channel behavior in beta cell lines with different secretory responses to glucose.

Authors:  G T Eddlestone; B Ribalet; S Ciani
Journal:  J Membr Biol       Date:  1989-07       Impact factor: 1.843

3.  Evidence for two calcium currents in insulin-secreting cells.

Authors:  L S Satin; D L Cook
Journal:  Pflugers Arch       Date:  1988-04       Impact factor: 3.657

4.  Heterogeneous expression of glucokinase among pancreatic beta cells.

Authors:  T L Jetton; M A Magnuson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

5.  Insulin secretory responses of a clonal cell line of simian virus 40-transformed B cells.

Authors:  S J Ashcroft; P Hammonds; D E Harrison
Journal:  Diabetologia       Date:  1986-10       Impact factor: 10.122

6.  The biphasic stimulation of insulin secretion by bombesin involves both cytosolic free calcium and protein kinase C.

Authors:  S L Swope; A Schonbrunn
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

7.  Bursting electrical activity in pancreatic beta cells caused by Ca(2+)- and voltage-inactivated Ca2+ channels.

Authors:  J Keizer; P Smolen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

8.  Chromomycin A2 potently inhibits glucose-stimulated insulin secretion from pancreatic β cells.

Authors:  Michael A Kalwat; In Hyun Hwang; Jocelyn Macho; Magdalena G Grzemska; Jonathan Z Yang; Kathleen McGlynn; John B MacMillan; Melanie H Cobb
Journal:  J Gen Physiol       Date:  2018-10-23       Impact factor: 4.086

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.